These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1693461)

  • 21. Monoclonal antibodies to bluetongue virus define two neutralizing epitopes and a hemagglutinating epitope.
    Mecham JO; Jochim MM
    Viral Immunol; 1990; 3(2):161-70. PubMed ID: 1694430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of monoclonal antibodies to epizootic hemorrhagic disease virus of deer (EHDV) and bluetongue virus by immunisation of mice with EHDV recombinant VP7 antigen.
    Zhou E; Afshar A
    Res Vet Sci; 1999 Jun; 66(3):247-52. PubMed ID: 10333467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Projection structure of VP6, the rotavirus inner capsid protein, and comparison with bluetongue VP7.
    Hsu GG; Bellamy AR; Yeager M
    J Mol Biol; 1997 Sep; 272(3):362-8. PubMed ID: 9325096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of bluetongue virus chimeric VP3 molecules and their interactions with VP7 protein to assemble into virus core-like particles.
    Tanaka S; Mikhailov M; Roy P
    Virology; 1995 Dec; 214(2):593-601. PubMed ID: 8553561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of correctly self-assembled bluetongue virus-like particles.
    Hewat EA; Booth TF; Roy P
    J Struct Biol; 1994; 112(3):183-91. PubMed ID: 7986645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VP7: an attachment protein of bluetongue virus for cellular receptors in Culicoides variipennis.
    Xu G; Wilson W; Mecham J; Murphy K; Zhou EM; Tabachnick W
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1617-23. PubMed ID: 9225038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and characterization of bluetongue virus serotype 21 VP7 antigen: C-terminal truncated protein has significantly reduced antigenicity.
    Hosamani M; Shimizu S; Hirota J; Kokuho T; Kubota T; Watanabe S; Ohta M; Muneta Y; Inumaru S
    J Vet Med Sci; 2011 May; 73(5):609-13. PubMed ID: 21187684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of a Bluetongue virus group-specific monoclonal antibody and application to a diagnostic competitive ELISA.
    Xu QY; Sun EC; Yang T; Feng YF; Geng HW; Wei T; Li JP; Sun L; Sun J; Xi N; Zhang Q; Wang HX; Liu EZ; Bu ZG; Wu DL
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):729-39. PubMed ID: 25038929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphogenesis of a bluetongue virus variant with an amino acid alteration at a neutralization site in the outer coat protein, VP2.
    Gould AR; Hyatt AD; Eaton BT
    Virology; 1988 Jul; 165(1):23-32. PubMed ID: 2838961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single point mutation in the VP7 major core protein of bluetongue virus prevents the formation of core-like particles.
    Le Blois H; Roy P
    J Virol; 1993 Jan; 67(1):353-9. PubMed ID: 8380082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of bluetongue virus particles by cryoelectron microscopy.
    Hewat EA; Booth TF; Roy P
    J Struct Biol; 1992; 109(1):61-9. PubMed ID: 1337461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of antigenic epitopes of monoclonal antibodies against the VP2 protein of the 25 serotype of bluetongue virus.
    Xie S; Shi Y; Gong R; Cui W; Jiang Y; Liu M; Wang L; Zhou H; Qiao X; Li Y; Xu Y; Tang L
    Vet Microbiol; 2018 Jun; 219():136-143. PubMed ID: 29778186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroup.
    White JR; Eaton BT
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1325-32. PubMed ID: 1693664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic topography of bluetongue virus 17.
    Grieder FB; Schultz KT
    Microb Pathog; 1990 Apr; 8(4):299-303. PubMed ID: 1696679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production, characterization and assay application of a purified, baculovirus-expressed, serogroup specific bluetongue virus antigen.
    Luo L; Sabara MI
    Transbound Emerg Dis; 2008 May; 55(3-4):175-82. PubMed ID: 18405340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9.
    Burroughs JN; O'Hara RS; Smale CJ; Hamblin C; Walton A; Armstrong R; Mertens PP
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1849-57. PubMed ID: 8046387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
    Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
    Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies against VP7 of bluetongue virus.
    Wang WS; Sun EC; Liu NH; Yang T; Xu QY; Qin YL; Zhao J; Feng YF; Li JP; Wei P; Zhang CY; Wu DL
    Hybridoma (Larchmt); 2012 Dec; 31(6):469-72. PubMed ID: 23244329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of domains in bluetongue virus VP3 molecules essential for the assembly of virus cores.
    Tanaka S; Roy P
    J Virol; 1994 May; 68(5):2795-802. PubMed ID: 8151751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically engineered multi-component virus-like particles as veterinary vaccines.
    Pearson LD; Roy P
    Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():381-9. PubMed ID: 8270267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.